• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

'nAb' the self-reactive activity in the COVID-19 combat.

作者信息

Narasimhan Madhusudhanan, Mahimainathan Lenin, Muthukumar Alagarraju

机构信息

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Signal Transduct Target Ther. 2021 Mar 2;6(1):105. doi: 10.1038/s41392-021-00518-2.

DOI:10.1038/s41392-021-00518-2
PMID:33654054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7921608/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdf/7925579/5404f822a3b6/41392_2021_518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdf/7925579/5404f822a3b6/41392_2021_518_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fdf/7925579/5404f822a3b6/41392_2021_518_Fig1_HTML.jpg

相似文献

1
'nAb' the self-reactive activity in the COVID-19 combat.在抗击新冠疫情中“中和抗体”的自身反应活性
Signal Transduct Target Ther. 2021 Mar 2;6(1):105. doi: 10.1038/s41392-021-00518-2.
2
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.COVID-19 患者体内针对 SARS-CoV-2 的中和抗体反应。
Indian J Med Res. 2020;152(1 & 2):82-87. doi: 10.4103/ijmr.IJMR_2382_20.
3
Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.使用高通量 SARS-CoV-2 抗体检测法选择 COVID-19 恢复期血浆的中和抗体效价。
Transfusion. 2021 Apr;61(4):1160-1170. doi: 10.1111/trf.16321. Epub 2021 Feb 18.
4
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.针对关注的 SARS-CoV-2 变体的中和抗体的表位分类和 RBD 结合特性。
Front Immunol. 2021 Jun 4;12:691715. doi: 10.3389/fimmu.2021.691715. eCollection 2021.
5
[Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].[新型冠状病毒肺炎患者严重急性呼吸综合征冠状病毒2病毒脱落情况及中和抗体水平]
Mikrobiyol Bul. 2022 Jul;56(3):416-431. doi: 10.5578/mb.20229704.
6
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.SARS-CoV-2 感染后的纵向中和抗体反应：台湾的康复队列研究。
J Microbiol Immunol Infect. 2023 Jun;56(3):506-515. doi: 10.1016/j.jmii.2023.03.004. Epub 2023 Mar 16.
7
Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.评估中国上海轻症 COVID-19 康复患者临床特征与中和抗体水平的相关性。
JAMA Intern Med. 2020 Oct 1;180(10):1356-1362. doi: 10.1001/jamainternmed.2020.4616.
8
A mathematical model of the within-host kinetics of SARS-CoV-2 neutralizing antibodies following COVID-19 vaccination.COVID-19 疫苗接种后 SARS-CoV-2 中和抗体的宿主内动力学的数学模型。
J Theor Biol. 2023 Jan 7;556:111280. doi: 10.1016/j.jtbi.2022.111280. Epub 2022 Oct 4.
9
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.新冠病毒感染康复者血浆中存在针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体依赖性细胞毒性（ADCC）
PLoS One. 2021 Mar 4;16(3):e0247640. doi: 10.1371/journal.pone.0247640. eCollection 2021.
10
A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers.一项针对完全接种疫苗的医护人员的 SARS-CoV-2 刺突蛋白受体结合域（RBD）IgG 水平和中和抗体的队列分析。
Clin Chem Lab Med. 2022 Apr 27;60(7):1110-1115. doi: 10.1515/cclm-2022-0322. Print 2022 Jun 27.

引用本文的文献

1
Structural Comparison and Drug Screening of Spike Proteins of Ten SARS-CoV-2 Variants.十种新冠病毒变异株刺突蛋白的结构比较与药物筛选
Research (Wash D C). 2022 Feb 1;2022:9781758. doi: 10.34133/2022/9781758. eCollection 2022.

本文引用的文献

1
Autoimmune Encephalitis Presenting With Malignant Catatonia in a 40-Year-Old Male Patient With COVID-19.一名40岁新冠肺炎男性患者出现恶性紧张症的自身免疫性脑炎
Am J Psychiatry. 2021 Jun;178(6):485-489. doi: 10.1176/appi.ajp.2020.20081236.
2
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms.新冠病毒感染患者出现神经系统症状时脑脊液自身抗体的高频出现。
Brain Behav Immun. 2021 Mar;93:415-419. doi: 10.1016/j.bbi.2020.12.022. Epub 2020 Dec 24.
3
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model.
一种治疗性非自身反应性 SARS-CoV-2 抗体可预防 COVID-19 仓鼠模型中的肺部病理。
Cell. 2020 Nov 12;183(4):1058-1069.e19. doi: 10.1016/j.cell.2020.09.049. Epub 2020 Sep 23.
4
Do cross-reactive antibodies cause neuropathology in COVID-19?交叉反应性抗体是否会导致 COVID-19 的神经病理学改变？
Nat Rev Immunol. 2020 Nov;20(11):645-646. doi: 10.1038/s41577-020-00458-y.
5
The continued epidemic threat of SARS-CoV-2 and implications for the future of global public health.持续的 SARS-CoV-2 疫情威胁及其对未来全球公共卫生的影响。
Curr Opin Virol. 2020 Feb;40:37-40. doi: 10.1016/j.coviro.2020.05.010. Epub 2020 Jun 4.